LIPID-POLYMER BASED NANOPARTICLES AS A NEW GENERATION THERAPEUTIC DELIVERY PLATFORM FOR ULCERATIVE COLITIS IN VITRO/IN VIVO EVALUATION

被引:0
|
作者
Shrivastava, Birendra [1 ]
Gopaiah, K. Venkata [1 ,2 ]
Rao, G. Sudhakara [3 ]
机构
[1] Jaipur Natl Univ, Jaipur, Rajasthan, India
[2] KL Coll Pharm, Koneru Lakshamaiah Educ Fdn, Guntur, Andhra Pradesh, India
[3] Vishwa Bharathi Coll Pharmaceut Sci, Guntur, Andhra Pradesh, India
来源
PHARMACOPHORE | 2019年 / 10卷 / 04期
关键词
Novel Drug Delivery systems; Ulcerative colitis; Nanoparticles; Nanocrystalline suspensions; DRUG-DELIVERY; COLON; RELEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The headway of the new medication organization frameworks (NDDS) was a theme of extraordinary enthusiasm for a large number of the pharmaceutical organizations since the advancement of the new particle forced a critical consumption of capital, HR and expert experience. Irritation in the digestive tract is called IBD. Ulcerative colitis (UC) and Crohn's infection were regularly called provocative gut sickness (IBD). Lipid nanoparticles (NC) were nanocrystalline suspensions, encased by lipids that are strong at room temperature. NCs are innovative of nanoparticle transporters, notwithstanding common ones, for example, liposomes, lipid emulsions, and polymeric nanoparticles. The NCs were set up by the hot homogenization technique utilizing an assortment of extents of stearic corrosiveand triglyceride monostearate, and Budesonide was picked as the model medication for the NC readiness. Guar gum was picked as a polysaccharide for the planning of NC. The readied NCs portrayed by molecule estimate, polydispersity file, surface charge, shape and surface morphology, embodiment productivity and in vitro examinations were performed in different disintegration media. The extra chosen F6 definition was completed for in vitro discharge energy, and in vivo strength examinations. The investigation started with preformulation contemplates on the chosen medication. A few parameters were contemplated, including bright (UV) absorbance, infrared range,liquefying point, solvency studies and differential checking calorimetry (DSC). The NC arrangement process was effectively reached out on a research facility scale, demonstrated simple execution and took into consideration a reproducible scattering of NC as far as molecule estimate, embodiment productivity, stacking effectiveness, polydispersity record, and surface morphology by SEM and TEM. Discharge ponders within sight of rodent cecal substance indicated more prominent medication discharge at 24 hours of disintegration, which was very different from the medication discharged without rodent cecal substance. It was because of the corruption of guar gum within sight of rodent cecal substance. The in vitro discharge energy examined in the F6 detailing. The detailing indicated Korse-Meyer-Peppas as a best-fit model and pursues the vehicle of Super Case-II. The results of in vivo studies revealed that lipid nanoparticles were the most advisable for colon-specific drug delivery of Budesonide. It ensures that lipid nanoparticles would be therapeutically useful in the colonic region. Copyright (C) 2013 - All Rights Reserved - Pharmacophore
引用
收藏
页码:15 / 27
页数:13
相关论文
共 50 条
  • [31] Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: in vitro and in vivo evaluation
    Zhu, Jiazhen
    Zou, Jiafeng
    Mu, Chaofeng
    Yang, Wenzhi
    Gu, Mancang
    Lin, Jinmin
    Song, Xinli
    Zheng, Hongyue
    Li, Fanzhu
    PHARMAZIE, 2019, 74 (01): : 39 - 46
  • [32] Quinone Propionic Acid- Based Redox- Triggered Polymer Nanoparticles for Drug Delivery: Computational Analysis and In Vitro Evaluation
    Bae, Jungeun
    Nael, Manal A.
    Jiang, Lingzhou
    Hwang, Patrick TaeJoon
    Mahdi, Fakhri
    Jun, Ho-Wook
    Elshamy, Wael M.
    Zhou, Yu-Dong
    Murthy, S. Narasimha
    Doerksen, Robert J.
    Jo, Seongbong
    JOURNAL OF APPLIED POLYMER SCIENCE, 2014, 131 (13)
  • [33] Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box-Behnken design, in vitro and in vivo evaluation
    Yasir, Mohd
    Sara, Udai Vir Singh
    Chauhan, Iti
    Gaur, Praveen Kumar
    Singh, Alok Pratap
    Puri, Dinesh
    Ameeduzzafar
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (08) : 1838 - 1851
  • [34] Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: In vitro and in vivo evaluation
    Zhao, Peiqi
    Wang, Hanjie
    Yu, Man
    Liao, Zhenyu
    Wang, Xianhuo
    Zhang, Fei
    Ji, Wei
    Wu, Bing
    Han, Jinghua
    Zhang, Haichang
    Wang, Huaqing
    Chang, Jin
    Niu, Ruifang
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (02) : 248 - 256
  • [35] In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release
    Moutaharrik, S.
    Maroni, A.
    Neut, C.
    Dubuquoy, C.
    Dubuquoy, L.
    Foppoli, A.
    Cerea, M.
    Palugan, L.
    Siepmann, F.
    Siepmann, J.
    Gazzaniga, A.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 183 : 13 - 23
  • [36] Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
    Chen, Fangyi
    Zeng, Yibin
    Qi, Xiaoxia
    Chen, Yanchao
    Ge, Zhe
    Jiang, Zengxin
    Zhang, Xinchao
    Dong, Yinmei
    Chen, Huaiwen
    Yu, Zuochong
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (07) : 2115 - 2127
  • [37] Experimental design-based optimization of lipid nanocarrier as delivery system against Mycobacterium species: in vitro and in vivo evaluation
    Hussain, Afzal
    Singh, Sandeep Kumar
    Verma, Priya Ranjan Prasad
    Singh, Neeru
    Ahmad, Farhan Jalees
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (07) : 910 - 927
  • [38] Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation
    Unnisa, Aziz
    Chettupalli, Ananda K.
    Al Hagbani, Turki
    Khalid, Mohammad
    Jandrajupalli, Suresh B.
    Chandolu, Swarnalatha
    Hussain, Talib
    PHARMACEUTICALS, 2022, 15 (05)
  • [39] Quality by Design approach for developmentand characterization of gabapentin-loaded solid lipid nanoparticles for intranasal delivery: In vitro, ex vivo , and histopathological evaluation
    Toksoy, Mahmut Ozan
    Asir, Firat
    Guzel, Mert Can
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2024, 27 (07) : 904 - 913
  • [40] Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery
    Liu, Ying
    Xie, Xingmei
    Chen, Haizhen
    Hou, Xuefeng
    He, Yuanzhi
    Shen, Junyi
    Shi, Jiangpei
    Feng, Nianping
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 29